首页 | 本学科首页   官方微博 | 高级检索  
检索        

国产香菇多糖合并化疗治疗晚期恶性肿瘤的临床研究
引用本文:姚阳,顾康生.国产香菇多糖合并化疗治疗晚期恶性肿瘤的临床研究[J].肿瘤防治研究,1998,25(5):393-396.
作者姓名:姚阳  顾康生
作者单位:安徽医科大学第一附属医院肿瘤科,合肥 230022
摘    要: 本文应用国产香菇多糖粉针剂(天地欣)合并化疗治疗晚期癌症患者43例,总有效率为55.8l%,单用化疗组37例,有效率为35.14%,两者有显著性差异(P<0.05) 其中胃癌组差异具极显著性(P<0.01).对45例患者进行免疫功能测试,结果表明,天地欣具有提高患者淋巴细胞转化率以及增强NK细胞活性的作用.我们认为,对晚期癌症患者化疗合并应用天地欣有改善机体免疫状况的作用,并可能提高化疗的缓解率.

关 键 词:香菇多糖  癌症  化疗  免疫状况

The Clinic Study for Treatment of Lentinan made in China combining with Chemotherapy for Late Cases with Malignant Tumors
Yao Yang, et al.The Clinic Study for Treatment of Lentinan made in China combining with Chemotherapy for Late Cases with Malignant Tumors[J].Cancer Research on Prevention and Treatment,1998,25(5):393-396.
Authors:Yao Yang  
Institution:Department of Oncology,Affiliated Hospital of Anhui Medical University,Hefei 230022
Abstract:43 late cases with malignant tumors were treated by lentinan (Tian Di Xin) combining with chemotherapy, total remission rate was 55. 81 % and significantly hither than that (35. 14%) of the 37 patients by chemotherapy only (P<0. 05). Among of them there was severely significant difference in gastric cancer patients (P<0. 01). Immunological function has been examined in 45 cases, the results showed that TianDiXin could significantly raise the percentage of lymphocyte transfer rate and enhance Natural killer cells activity of cancer patients. We consider that TiandiXin could improve the immunological .condition and raise the remission rate of chemotherapy for cancer patients.
Keywords:Lentinan  Cancer  Chemotherapy  Immunological Condition
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号